Cannabigerol is a potential therapeutic agent in a novel combined therapy for glioblastoma - Lah, T T; Novak, M; Pena Almidon, M A; Marinelli, O; Žvar Baškovič, B; Majc, B; Mlinar, M; Bošnjak, R; Breznik, B; Zomer, R (Cells, 2021)